Clinical Trial Update: Study to Evaluate Safety, Efficacy and Tolerability of Clobetasol Propionate for Chronic Hand Dermatitis [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating the safety, efficacy and tolerability of clobetasol propionate for chronic hand dermatitis has completed and posted results in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hand Dermatitis

Drugs mentioned

• CLOBETASOL PROPIONATE (Clobetasol propionate)

Snippet

Sponsor: Stiefel, a GSK Company | Conditions: Hand Dermatosis | Phase 4 | Status: COMPLETED | Results posted: 2010-09-28